[ad_1]
lakshmiprasad S
Aligos Therapeutics (NASDAQ:ALGS) on Wednesday mentioned it had responded to allegations of theft made by Janssen Biopharma and had filed counterclaims in courtroom in opposition to the Johnson & Johnson (NYSE:JNJ) unit.
In March, Janssen had filed a criticism in a California courtroom in opposition to ALGS and its co-founders – CEO Lawrence Blatt and president Leonid Beigelman.
In response to a media report, Janssen had alleged that ALGS was constructed on mental property and knowledge stolen from it. Janssen additionally claimed that Blatt and Beigelman had developed a line of hepatitis B virus (HBV) focusing on merchandise utilizing its sources and shaped ALGS.
ALGS mentioned its response filed in California State Superior Court docket for the County of San Mateo recognized publicly out there data, earlier work expertise, publications and patents which had been used to construct its HBV portfolio.
“The response additional outlines and paperwork that every one work was carried out by Aligos staff after leaving Janssen Biopharma,” ALGS mentioned in Wednesday’s assertion.
Moreover, the corporate mentioned it had filed counterclaims in opposition to Janssen alleging that it had engaged in “unfair competitors” and “promissory fraud.”
Blatt and Beigelman additionally joined ALGS in submitting the counterclaims.
ALGS inventory +1.8% to $1.12 after hours, whereas shares of JNJ have been flat.
In today's tech-driven world, electronic companies play a crucial role in shaping modern life, from…
Hey there, fellow dreamers! Ever fantasized about hitting the jackpot and living the life of…
The Some Remarkable Plus woodworking dust masque combines advanced technology with design elements for a…
Reclaim catchers speed up cleaning time for dab rigs by collecting residue that could build…
Barn exhaust fans provide airflow that reduces heating stress, makes livestock far healthier and happier,…
Your dog's health depends upon consuming a balanced diet, providing you with essential vitamins, minerals,…